Abstract
PurposeTo compare the efficacy, safety, predictability and visual quality between implantable collamer lens (ICL) implantation and small incision lenticule extraction (SMILE) for high myopia correction in adults.MethodsA systematic review and meta-analysis was conducted. A comprehensive literature search was done based on databases including PubMed, Science Direct, Embase, and the Cochrane Central Register of Controlled Trials. The efficacy index, safety index, changes in Snellen lines of corrected distance visual acuity (CDVA), predictability (difference between post-operative and attempted spherical equivalent error, SER), incidence of halos, and change in higher-order aberrations (HOAs) were compared. Mean difference (MD) and 95% confidence interval (CI) was used to estimate continuous outcomes, risk ratio (RR) and 95%CI was used to estimate categorical outcomes.ResultsFive observational studies involving 555 eyes were included in this review. Studies’ sample sizes (eyes) ranged from 76 to 197. Subjects’ refraction ranged from -6 diopter (D) to -12D. Study duration of most researches were 6 months or 12 months. Compared to SMILE, ICL implantation showed better efficacy index (MD=0.09, 95%CI:0.01 to 0.16) and better safety index (MD=0.08, 95%CI: 0.00 to 0.16). Compared with SMILE, more ICL-treated eyes gained one or more Snellen lines of CDVA (RR=1.54, 95%CI:1.28 to 1.86), more gained two or more lines (RR=2.09, 95%CI:1.40 to 3.13), less lost one or more lines (RR=0.17, 95%CI:0.05 to 0.63). There was no difference in predictability between two treatments, RRs of predictability of within ±0.5D and ±1D were 1.13 (95%CI: 0.94 to 1.36) and 1.00 (95%CI: 0.98 to 1.02). Compared with SMILE, ICL implantation came with a higher risk of halos [RR=1.79, 95%CI: 1.48 to 2.16] and less increase in total HOAs (MD=-0.23, 95%CI: -0.42 to -0.03).ConclusionCompared with SMILE, ICL implantation showed a higher risk of halos, but equal performance on SER control, and better performance on efficacy index, safety index, CDVA improvement and HOAs control. Overall, ICL implantation might be a better choice for high myopia correction in adults.
Highlights
Nowadays, it is well accepted to use small incision lenticule extraction (SMILE) to correct low-to-moderate myopia [1, 2]
Implantable collamer lens (ICL) implantation was another promising way for high myopia correction [9], the postoperative spherical equivalent error (SER) was reported to be predictable [10, 11] and stable [12, 13]
Moshirfar M [17] and coworkers thought SMILE might be comparable to ICL for high myopia correction, Wei R [18] reported both treatments showed compared performance for high myopia correction
Summary
It is well accepted to use small incision lenticule extraction (SMILE) to correct low-to-moderate myopia [1, 2]. Implantable collamer lens (ICL) implantation was another promising way for high myopia correction [9], the postoperative spherical equivalent error (SER) was reported to be predictable [10, 11] and stable [12, 13]. A few studies compared ICL implantation with SMILE for high myopia correction, conclusions from different studies were controversial. Siedlecki J [16] and coworkers reported ICL implantation yielded better uncorrected distance visual acuity, better refractive accuracy, and fewer higher-order aberrations (HOAs) than SMILE. Moshirfar M [17] and coworkers thought SMILE might be comparable to ICL for high myopia correction, Wei R [18] reported both treatments showed compared performance for high myopia correction
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.